table of content
1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Diagnostics Overall Market Size
2.1 Global Next Generation Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Next Generation Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostics Players in Global Market
3.2 Top Global Next Generation Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Next Generation Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Next Generation Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 DNA Microarrays
4.1.5 Others
4.2 By Type - Global Next Generation Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Next Generation Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Next Generation Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Next Generation Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Next Generation Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Next Generation Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Next Generation Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Next Generation Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Next Generation Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Next Generation Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Next Generation Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Next Generation Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Next Generation Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Next Generation Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Next Generation Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Next Generation Cancer Diagnostics Market Size, 2018-2029
7 Next Generation Cancer Diagnostics Companies Profiles
7.1 Cepheid
7.1.1 Cepheid Company Summary
7.1.2 Cepheid Business Overview
7.1.3 Cepheid Next Generation Cancer Diagnostics Major Product Offerings
7.1.4 Cepheid Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Cepheid Key News & Latest Developments
7.2 Koninklijke Philips N.V
7.2.1 Koninklijke Philips N.V Company Summary
7.2.2 Koninklijke Philips N.V Business Overview
7.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Major Product Offerings
7.2.4 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Koninklijke Philips N.V Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Next Generation Cancer Diagnostics Major Product Offerings
7.4.4 Qiagen Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Qiagen Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Next Generation Cancer Diagnostics Major Product Offerings
7.5.4 Novartis AG Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Next Generation Cancer Diagnostics Major Product Offerings
7.6.4 Abbott Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Major Product Offerings
7.7.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Opko Health
7.8.1 Opko Health Company Summary
7.8.2 Opko Health Business Overview
7.8.3 Opko Health Next Generation Cancer Diagnostics Major Product Offerings
7.8.4 Opko Health Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Opko Health Key News & Latest Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Company Summary
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics Next Generation Cancer Diagnostics Major Product Offerings
7.9.4 Myriad Genetics Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Myriad Genetics Key News & Latest Developments
7.10 Agilent Technologies
7.10.1 Agilent Technologies Company Summary
7.10.2 Agilent Technologies Business Overview
7.10.3 Agilent Technologies Next Generation Cancer Diagnostics Major Product Offerings
7.10.4 Agilent Technologies Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Agilent Technologies Key News & Latest Developments
7.11 GE Healthcare
7.11.1 GE Healthcare Company Summary
7.11.2 GE Healthcare Business Overview
7.11.3 GE Healthcare Next Generation Cancer Diagnostics Major Product Offerings
7.11.4 GE Healthcare Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 GE Healthcare Key News & Latest Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Company Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Next Generation Cancer Diagnostics Major Product Offerings
7.12.4 PerkinElmer Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.12.5 PerkinElmer Key News & Latest Developments
7.13 Genomic Health
7.13.1 Genomic Health Company Summary
7.13.2 Genomic Health Business Overview
7.13.3 Genomic Health Next Generation Cancer Diagnostics Major Product Offerings
7.13.4 Genomic Health Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Genomic Health Key News & Latest Developments
7.14 Illumina
7.14.1 Illumina Company Summary
7.14.2 Illumina Business Overview
7.14.3 Illumina Next Generation Cancer Diagnostics Major Product Offerings
7.14.4 Illumina Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Illumina Key News & Latest Developments
7.15 Hologic
7.15.1 Hologic Company Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Next Generation Cancer Diagnostics Major Product Offerings
7.15.4 Hologic Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Hologic Key News & Latest Developments
7.16 Almac Group
7.16.1 Almac Group Company Summary
7.16.2 Almac Group Business Overview
7.16.3 Almac Group Next Generation Cancer Diagnostics Major Product Offerings
7.16.4 Almac Group Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Almac Group Key News & Latest Developments
7.17 Janssen Global Services
7.17.1 Janssen Global Services Company Summary
7.17.2 Janssen Global Services Business Overview
7.17.3 Janssen Global Services Next Generation Cancer Diagnostics Major Product Offerings
7.17.4 Janssen Global Services Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.17.5 Janssen Global Services Key News & Latest Developments
7.18 Sysmex Corporation
7.18.1 Sysmex Corporation Company Summary
7.18.2 Sysmex Corporation Business Overview
7.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Major Product Offerings
7.18.4 Sysmex Corporation Next Generation Cancer Diagnostics Revenue in Global Market (2018-2023)
7.18.5 Sysmex Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
